The Manila Times

Sleep Apnea Clinical Trial Pipeline Shows Potential with Active Contributions from 22+ Key Companies | DelveInsight

The sleep apnea clinical trial analysis report delivers important insights into ongoing research of 24+ pipeline sleep apnea drugs, clinical strategies, upcoming therapeutics, and commercial analysis.
Nasdaq

Nyxoah Launches Genio System In U.S. With First Commercial Implants For Sleep Apnea

(RTTNews) - Nyxoah SA (NYXH), a medical technology company specializing in innovative treatments for Obstructive Sleep Apnea (OSA), announced the successful implantation of its Genio system in the ...
Nasdaq

Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide

Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution This collaboration unites Dario's ...
KRQE

Apnimed Announces New Leadership Appointments as the Company Builds Its Commercial and Human Resource Capabilities in Support of AD109, a Potential Nighttime Oral Treatment for ...

CAMBRIDGE, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep ...

Vivos Therapeutics Reports Progress in Material Cost Reductions and Revenue Growth Initiatives

A 2019 analysis published in The Lancet Respiratory Medicine estimated that approximately 936 million adults aged 30 to 69 worldwide have OSA. Through technology, education, provider partnerships and ...